Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

Pliant Therapeutics, Inc.

PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001746473

No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.

Holders of 5% or more of PLRX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Pliant Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of PLRX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Tang Capital Management LLC13D9.60%5.86M sharesNewMar 10, 20251 filingMar 10, 2025SEC
ADAR1 Capital Management, LLC13G8.90%5.51M sharesNewAug 14, 20261 filingAug 14, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

53 Schedule 13D and 13G filings on Pliant Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on PLRX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20269:31 PM ETADAR1 Capital Management, LLCand 1 other13G8.90%5.51M sharesNewJun 30, 2026SEC
Aug 14, 20264:05 PM ETCitadel Advisors LLCand 6 others13G/A3.50%2.14M shares−1.50 ppfrom 5.00%Below 5%Jun 30, 2026SEC
Feb 17, 20264:29 PM ETPoint72 Asset Management, L.P.and 2 others13G/A0.10%46.5K shares−6.60 ppfrom 6.70%Below 5%Dec 31, 2025SEC
Feb 17, 20263:21 PM ETWoodline Partners LP13G/A3.30%2.03M shares−4.00 ppfrom 7.30%Below 5%Dec 31, 2025SEC
Feb 9, 20266:13 PM ETCitadel Advisors LLCand 6 others13G5.00%3.04M shares+0.10 ppfrom 4.90%Feb 2, 2026SEC
Jan 30, 20267:11 PM ETCitadel Advisors LLCand 6 others13G4.90%3.04M shares0.00 ppfrom 4.90%Below 5%Jan 23, 2026SEC
Jan 22, 20267:02 PM ETCitadel Advisors LLCand 6 others13G4.90%2.99M sharesNewBelow 5%Jan 14, 2026SEC
Jan 8, 20264:03 PM ETMorgan Stanley13G/A0.90%545.2K shares−5.20 ppfrom 6.10%Below 5%Dec 31, 2025SEC
Nov 14, 20254:17 PM ETWoodline Partners LP13G7.30%4.50M sharesNewSep 30, 2025SEC
Nov 14, 20258:22 AM ETDeep Track Capital, LPand 2 others13G/A0.00%0 shares−6.43 ppfrom 6.43%Below 5%Sep 30, 2025SEC
Sep 4, 20255:13 PM ETPoint72 Asset Management, L.P.and 2 others13G6.70%4.09M sharesNewAug 27, 2025SEC
Aug 14, 20258:49 AM ETDeep Track Capital, LPand 2 others13G/A6.43%3.95M shares–Jun 30, 2025SEC
Aug 6, 20252:12 PM ETMorgan Stanley13G6.10%3.74M sharesNewJun 30, 2025SEC
Jul 29, 20252:22 PM ETVanguard Group Inc13G/A4.89%3.00M shares–Below 5%Jun 30, 2025SEC
Jul 17, 20258:12 PM ETBlackRock, Inc.13G/A3.40%2.10M shares–Below 5%Jun 30, 2025SEC
May 15, 20254:39 PM ETParadigm Biocapital Advisors LPand 3 others13G/A0.00%0 shares–Below 5%Mar 31, 2025SEC
May 14, 202510:45 AM ETPrice T Rowe Associates Inc13G/A0.10%87.7K shares–Below 5%Mar 31, 2025SEC
Mar 10, 20255:24 PM ETTang Capital Management LLCand 6 others13D9.60%5.86M sharesNewMar 3, 2025SEC
Mar 7, 202510:01 AM ETFMR LLCand 1 other13G/A0.20%132.0K shares–Below 5%Feb 28, 2025SEC
Feb 14, 20258:01 PM ETRedmile Group, LLCand 1 other13G/A4.80%2.90M shares–Below 5%Dec 31, 2024SEC
Nov 14, 2024First Light Asset Management, LLC13G/AOld format–––SEC
Nov 14, 2024Blue Owl Capital Holdings LP13G/AOld format–––SEC
Nov 14, 2024Redmile Group, LLC13GOld format–––SEC
Nov 14, 2024Price T Rowe Associates Inc13G/AOld format–––SEC
Nov 12, 2024Laurion Capital Management LP13G/AOld format–––SEC
Oct 4, 2024Paradigm Biocapital Advisors LP13GOld format–New–SEC
Feb 14, 2024First Light Asset Management, LLC13GOld format–New–SEC
Feb 14, 2024Third Rock Ventures III, L.P.13G/AOld format–––SEC
Feb 14, 2024Deep Track Capital, LP13G/AOld format–––SEC
Feb 14, 2024Blue Owl Capital Holdings LP13GOld format–New–SEC
Feb 14, 2024Redmile Group, LLC13G/AOld format–––SEC
Feb 14, 2024Price T Rowe Associates Inc13GOld format–New–SEC
Feb 13, 2024Vanguard Group Inc13GOld format–New–SEC
Feb 9, 2024FMR LLC13G/AOld format–––SEC
Feb 8, 2024Laurion Capital Management LP13GOld format–New–SEC
Jan 25, 20244:59 PM ETBlackRock Inc.13GOld format–New–SEC
Mar 20, 2023Deep Track Capital, LP13GOld format–New–SEC
Feb 14, 2023Third Rock Ventures III, L.P.13G/AOld format–––SEC
Feb 14, 2023Redmile Group, LLC13G/AOld format–––SEC
Feb 13, 2023CHI Advisors LLC13G/AOld format–––SEC
Feb 9, 2023FMR LLC13G/AOld format–––SEC
Aug 31, 2022Novartis Institutes for BioMedical Research, Inc.13G/AOld format–––SEC
Aug 10, 2022FMR LLC13G/AOld format–––SEC
Jun 10, 2022FMR LLC13G/AOld format–––SEC
Feb 14, 2022Eventide Asset Management, LLC13G/AOld format–––SEC
Feb 14, 2022Redmile Group, LLC13G/AOld format–––SEC
Feb 11, 2022CHI Advisors LLC13G/AOld format–––SEC
Feb 9, 2022FMR LLC13G/AOld format–––SEC
Mar 2, 2021CHI Advisors LLC13GOld format–New–SEC
Feb 16, 2021Third Rock Ventures III, L.P.13GOld format–New–SEC

Form 144: proposed insider sales

3 notices from officers, directors and other affiliates planning to sell Pliant Therapeutics, Inc. shares, newest first.

Form 144 notices for PLRX
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Jan 22, 20254:23 PM ETMichael OuimetteOfficer10.2K$113.2KJan 22, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 3, 20234:11 PM ETJohannes P HullOfficer34.9K$660.0KAug 3, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jul 20, 20234:06 PM ETMichael OuimetteOfficer4.75K$84.7KJul 20, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC